Mastocytosis, Systemic - 25 Studies Found
Completed |
: Everolimus (RAD001) as Therapy for Patients With Systemic Mastocytosis : Systemic Mastocytosis : 2007-03-19 : Drug: RAD001 (Everolimus) Oral RAD001 10 mg daily for 30 days |
Completed |
: Use of Tamoxifen in Systemic Mastocytosis : Systemic Mastocytosis : 2007-12-25 |
Completed |
: Imatinib in KIT-negative Systemic Mastocytosis : Systemic Mastocytosis : 2011-02-16 : Drug: Imatinib Mesylate
|
Recruiting |
: Diagnostic Value of Bone Marrow Tryptase in Systemic Mastocytosis : Systemic Mastocytosis : 2015-05-05 : Procedure: Mastocytosis diagnosis Some samples will be extracted from bone marrow aspirate and periphera |
Recruiting |
: Cladribine Plus Pegylated Interpheron Alfa-2a in Systemic Mastocytosis : Systemic Mastocytosis : 2012-05-16 : Drug: Cladribine and pegylated interpheron alpha-2a Cladri |
Recruiting |
: Midostaurin in Indolent Systemic Mastocytosis : Indolent Systemic Mastocytosis : 2013-08-07 : Drug: Midostaurin, Midostaurin, twice daily 100 mg orally, continuously for 6 months |
Terminated |
: Obatoclax for Systemic Mastocytosis :
: 2009-06-09 : Drug: Obatoclax Mesylate 30 mg given by vein over 3 hours on Days 1-3 of each 14-day study cycle. |
Completed |
: Treatment of Indolent Systemic Mastocytosis With PA101 :
|
Completed |
: Ontak (Denileukin Diftitox) in Patients With Systemic Mastocytosis (SM) :
: 2007-06-26 : Drug: Ontak (Denileukin Diftitox) 9 µg/kg by vein Days 1-5 of a 21 day cycle. |
Recruiting |
: Ibrutinib in Treating Patients With Advanced Systemic Mastocytosis :
: |